UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000022274
Receipt No. R000025656
Scientific Title Relation of plasma xanthine oxidation-reduction enzyme activity and various factors in patients with cardiovascular disease and/or heart failure
Date of disclosure of the study information 2016/05/11
Last modified on 2020/11/13 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Relation of plasma xanthine oxidation-reduction enzyme activity and various factors in patients with cardiovascular disease and/or heart failure
Acronym Xanthine oxidation-reduction enzyme activity in patients with cardiovascular disease
Scientific Title Relation of plasma xanthine oxidation-reduction enzyme activity and various factors in patients with cardiovascular disease and/or heart failure
Scientific Title:Acronym Xanthine oxidation-reduction enzyme activity in patients with cardiovascular disease
Region
Japan

Condition
Condition cardiovascular disease
heart failure
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the plasma XOR activity in the patients with cardiovascular disease.

Basic objectives2 Others
Basic objectives -Others To evaluate the plasma XOR activity in the patients with heart failure.
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Measured value of the plasma XOR activity in patients with cardiovascular disease
Key secondary outcomes Measured value of the plasma XOR activity in patients with heart failure

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Male or female patients over 20 years old at time the subjects sign the Informed Consent Form (ICF).
Key exclusion criteria Patients who are judged as inappropriate for inclusion by physicians.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Nobukazu Ishizaka
Organization Osaka Medical College
Division name Department of Cardiology
Zip code
Address 2-7 Daigakucho, Takatuski, Osaka
TEL 072-683-1221
Email ishizaka@osaka-med.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yumiko Kanzaki
Organization Osaka Medical College
Division name Department of Cardiology
Zip code
Address 2-7 Daigakucho, Takatuski, Osaka
TEL 072-683-1221
Homepage URL
Email in3089@poh.osaka-med.ac.jp

Sponsor
Institute Department of Cardiology
Osaka Medical College
Institute
Department

Funding Source
Organization SANWA KAGAKU KENKYUSHO CO.,LTD
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization JAPAN

Other related organizations
Co-sponsor SANWA KAGAKU KENKYUSHO CO.,LTD
Name of secondary funder(s) not applicable

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 05 Month 11 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2016 Year 05 Month 02 Day
Date of IRB
2016 Year 05 Month 02 Day
Anticipated trial start date
2016 Year 05 Month 11 Day
Last follow-up date
2019 Year 03 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information none

Management information
Registered date
2016 Year 05 Month 11 Day
Last modified on
2020 Year 11 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025656